2024 Tandem Meetings

Melissa BadamoAnemia | March 18, 2024

The researchers evaluated surveys sent between 2015 and 2023 to patients with severe aplastic anemia who underwent HSCT.

Patrick DalyHematology | March 9, 2024

Noninfectious pulmonary complications after HSCT for SCD were associated with several transplant-related risk factors.

Melissa BadamoAnemia | March 11, 2024

Requiring dialysis before HSCT is associated with “very poor outcomes,” according to the study.

Patrick DalySickle Cell Disease | March 9, 2024

A myeloablative conditioning regimen containing thiotepa had promising efficacy and safety in patients with severe SCD.

Patrick DalyAnemia | March 14, 2024

Fludarabine, cyclophosphamide, and ATG had superior outcomes versus historical outcomes of non-ATG conditioning.

Patrick DalySickle Cell Disease | February 26, 2024

Reduction of hemolysis significantly predicted postinfusion transduction efficacy in patients with SCD treated with lovo-cel.

Melissa BadamoSickle Cell Disease | February 22, 2024

Exa-cel eliminated RBC transfusions in patients with transfusion-dependent β-thalassemia.

Patrick DalyAnemia | February 22, 2024

HSCT with a matched unrelated or haploidentical donor was a promising alternative in patients with severe aplastic anemia.